PP01.10 A Randomized, Open-Label Phase 2 Study of the TORC 1/2 Inhibitor Sapanisertib in Relapsed/Refractory (R/R) NFE2L2 (NRF2)-Mutated and Wild-Type (WT) Squamous Non-Small Cell Lung Cancer (sqNSCLC)

Subjects

Subjects :

Pulmonary and Respiratory Medicine
Oncology

Details

ISSN :

15560864

Volume :

18

Database :

OpenAIRE

Journal :

Journal of Thoracic Oncology

Accession number :

edsair.doi...........89c21c74c9c12d68ed51a084e3c4ccb8

Full Text :

https://doi.org/10.1016/j.jtho.2022.09.036